Literature DB >> 11311237

In vitro ubiquitination of cyclin D1 by ROC1-CUL1 and ROC1-CUL3.

I Maeda1, T Ohta, H Koizumi, M Fukuda.   

Abstract

Overexpression of cyclin D1 has been implicated in a variety of tumors, such as breast cancers, gastrointestinal cancers and lymphomas. Both gene amplification and protein degradation mediated by ubiquitin (Ub)-dependent proteolysis regulate the abundance of cyclin D1. Here we report that ROC1 interacted with all three D type cyclins in vivo but did not bind to other cyclins tested. The ROC1-CUL1 and ROC1-CUL3, but not ROC1-CUL2, -CUL3 and -CUL4, immunocomplexes promoted polyubiquitination of bacterially purified cyclin D1 in vitro. RING finger mutations of ROC1 eliminated the Ub ligase activity toward cyclin D1. In all cases the ubiquitination of cyclin D1 was accompanied by autoubiquitination of the cullins. The results suggest the involvement of ROC1-cullin ligases in cyclin D1 ubiquitination and a potential mechanism whereby the cullin subunit is ubiquitinated itself while ubiquitinating a substrate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311237     DOI: 10.1016/s0014-5793(01)02343-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.

Authors:  Mukul K Mittal; Kshipra Singh; Smita Misra; Gautam Chaudhuri
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

2.  The inherited blindness associated protein AIPL1 interacts with the cell cycle regulator protein NUB1.

Authors:  Dayna T Akey; Xuemei Zhu; Michael Dyer; Aimin Li; Adam Sorensen; Seth Blackshaw; Taeko Fukuda-Kamitani; Stephen P Daiger; Cheryl M Craft; Tetsu Kamitani; Melanie M Sohocki
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

3.  Protective Effect of Genistein on Cyclin D1 Expression in Malignant Ocular Melanoma Cells.

Authors:  Yasmin Sani Aprilliantina; Hera Dwi Novita; Elfina G Sadono; Rosy Aldina
Journal:  Med Arch       Date:  2021-06

4.  The ASK1 and ASK2 genes are essential for Arabidopsis early development.

Authors:  Fuquan Liu; Weimin Ni; Megan E Griffith; Zhiyuan Huang; Changqing Chang; Wen Peng; Hong Ma; Daoxin Xie
Journal:  Plant Cell       Date:  2003-12-19       Impact factor: 11.277

5.  MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection.

Authors:  Sophie Blanié; Jacqueline Gelfi; Stéphane Bertagnoli; Christelle Camus-Bouclainville
Journal:  Virol J       Date:  2010-03-08       Impact factor: 4.099

6.  The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase.

Authors:  Kwang-Jin Oh; Anna Kalinina; Jing Wang; Keiko Nakayama; Keiichi I Nakayama; Srilata Bagchi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells.

Authors:  Hidenori Hattori; Xueqing Zhang; Yonghui Jia; Kulandayan K Subramanian; Hakryul Jo; Fabien Loison; Peter E Newburger; Hongbo R Luo
Journal:  Blood       Date:  2007-04-09       Impact factor: 22.113

8.  Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues.

Authors:  Michael J Fay; Kenneth A Longo; George A Karathanasis; David M Shope; Craig J Mandernach; Jason R Leong; Alfred Hicks; Kenneth Pherson; Amyna Husain
Journal:  Mol Cancer       Date:  2003-11-25       Impact factor: 27.401

9.  The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase.

Authors:  V Subramaniam; H Li; M Wong; R Kitching; L Attisano; J Wrana; J Zubovits; A M Burger; A Seth
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

Review 10.  Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases.

Authors:  Sang-Min Jang; Christophe E Redon; Bhushan L Thakur; Meriam K Bahta; Mirit I Aladjem
Journal:  Exp Mol Med       Date:  2020-10-02       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.